and the blood directed to a jugular vein. The coronary sinus cannula contained an external tube that entered the lumen of the cannula 1 cm from the tip and was bent so that fluid injected through it moved in the same direction as the blood flow through the cannula.
During collection of a coronary sinus blood sample, an ice-cold isotonic solution of NaCl (volume of l-2 times that of the blood collected) was injected through this tube, cooling and diluting the blood at the level of the coronary sinus. Arterial blood samples taken from the aorta were treated in the same way as the venous samples. All blood samples were collected in centrifuge tubes immersed in ice. A flow diagram of the procedures used in processing the blood samples is presented in Fig. 2 .
Each sample was rapidly transferred to a refrigerated centrifuge, and separation of the cellular elements from the diluted plasma was usually achieved within 15-l 8 The diluted plasma was immersed in boiling water for 10-l 5 min to destroy any remaining enzymatic activity. It was then subjected to ultrafiltration, using a filter consisting of a cylindrical nylon frame covered tightly by a sock of cellulose dialysis tubing with a mean pore radius of 24 A (LKB 6300A ultrafilter). The filters were completely immersed in the diluted boiled plasma cooled to 4 C and vacuum was applied. Complete filtration took approximately 24 hr and removed protein with molecular weights greater than about 30,000. The ultrafiltrates were concentrated by vacuum evaporation at 65 C to a volume between 50 and 75 ml. To this concentrated ultrafiltrate, 100 mg of activated charcoal (0.5-l .O mg charcoal/ 1 ml whole blood) were added for adsorption of the purine derivatives. The charcoal suspension was shaken for 3 hr, the charcoal separated by centrifugation ( 1,400 X g for 10 min), and the supernatant discarded.
The charcoal was washed twice with 20 ml of distilled water, centrifuged, and the wash discarded. The washed charcoal was transferred to celite columns (0.7 g of celite in tube of 0.8-cm diameter) and the purine derivatives were eluted from the charcoal celite columns with 350 ml of 50 % ethanol (v/v) at a pH of 10 (adjusted with NHdOH) over a period of 15-20 hr. The eluate was dried under vacuum evaporation at 65 C and the remaining solid was redissolved in 1.0 ml of water and chromatographed.
from the plates and the substances were eluted from the cellulose by washing five times with 1-2 ml of 50 % (v/v) aqueous ethanol, adjusted to pH 10 with NH40H. For each elution the suspension was stirred 30 min and the supernatants collected by centrifugation for 10 min at 1,330 X g* The combined supernatants were dried with a stream of filtered air and the residue dissolved in 1.5 ml H20. Centrifugation was repeated and 1.2 ml of the supernatant was used for enzymatic quantitation (see beJaw The percent recoveries were 94.8 + 1.9 for adenosine, 90.4 =t 1.5 for hypoxanthine, and 92.2 * 2.7 for inosine.
For the blood samples both ascending chromatographic systems were utilized.
In the first chromatographic step (C-I, Fig. Z) , the products from 100 ml of whole blood were spotted in a 17-cm line, and the chromatogram waO developed with 15 % ethanol (v/v) at pH 7.0 and 4 C. This chromatogram yielded two fractions, one containing inosine and hypoxanthine, and the other containing adenosine.
The '<adenosine area" was scraped from the plate, extracted with 50 70 ethanol
Step # Arterial
(1)
(5) (6)
(8) The thin-layer chromatographic plates were spread with ion-exchange cellulose in the phosphate form (Selectacel no, 69 phosphate, from Carl Schleicher & Schuell Co.). The phosphate cellulose, as supplied, contains a yellow pigment which moves with the solvent front during chromatography.
This pigment was removed by washing the cellulose four times with 25 % (v/v) aqueous ethanol, 20 ml/g, and then twice with water, 20 ml/g; with each washing the suspension was shaken for 5 min, centrifuged at 850 X g for 5 min, and the supernatant discarded. Slurries containing 12 g phosphate cellulose and 77 ml water (50 ml contained in washed cellulose + 27 additional) were spread on 20 x 20 cm glass plates in a thickness of 0.5 mm. To evaluate the chromatographic system with respect to separation and recovery of purine derivatives, plates were spotted with 0.02-0.03 pm&/g of pure purine compounds (Nutritional Biochemical Co.). Ascending chromatograms were developed for 4 hr at 4Cwitheither 157 ( / ) q o v v a ueous ethanol at pH 7.0 or with 50 % (v/v) aqueous ethanol, adjusted to pH 10 with NH,OH.
Cellulose from fluorescent spots was scraped Since large volumes (600-800 ml) of blood were required, a femoral artery of a donor dog was connected to a femoral artery of the experimental animal so that both dogs shared in the bleeding. To compensate for the blood loss, 600 ml of 6 % dextran in isotonic saline were administered intravenously to the donor dog over the duration of the experiment. Adenosine recovery studies. To each IOO-ml aliquot of warm (37 C), fresh, heparinized dog blood (obtained from a donor animal) 0, 20, 40, 80, 160, or 400 mpmoles of adenosine dissolved in 10 ml of isotonic saline were added and mixed by shaking. The addition of adenosine took approximately 5 set and 200 ml of ice-cold saline were then added to the blood 5-10 set later. This experiment was repeated eight times.
In three experiments, adenosine was continuously infused into the coronary sinus cannula through its lateral tube while 100 ml of coronary sinus blood were collected. An additional length of tubing was added to the coronary sinus cannula so that approximately 10 set were required for the blood to travel from the site of adenosine infusion to the collection vessel. The collection vessel was immersed in ice and contained 200 ml of ice-cold isotonic saline.
In 11 experiments, adenosine dissolved in 0.9 % NaCl was infused into the circumflex branch of the left coronary artery with a syringe pump (Sage model 255W) at different rates during constant-pressure perfusion of the c vessel with ar sine solution terial was blood. The 0.9 ml/min rate of flo-w or less. In of the adenofive of these experiments, coronary sinus blood samples of approximately 100 ml each were collected (total of 8 collections) during the intracoronary infusion of 100 and 200 mpmoles adenosine/min.
RESULTS
Under ultraviolet illumination, a spot in the same position as hypoxanthine was evident in all chromatograms of coronary venous blood samples collected during the period of reactive hyperemia, whereas only a faint spot was detectable in about one-third of the chromatograms of control coronary venous and arterial blood samples. A spot in the inosine position was visible in the coronary venous blood samples collected after ischernia but not in chromatograms of the control coronary venous or arterial blood samples. Since all of the inosine and hypoxanthine may not have been located at the visible spots on the first chromatograrn, the cellulose corrcsponding to the area of the standard (Fig. 3 , between arrows 3 and 4) was always extracted and the products of the extraction submitted to the quantitation procedure for inosine and hypoxanthine (Fig. 2, step 8) . The values for inosinc and hypoxanthine in arterial and coronary venous control samples are presented in Table 1 and those of the coronary venous blood samples collected after the period of coronary occlusion are given in Table 2 .
The amounts of hypoxanthinc in arterial and coronary venous control samples were smaller than those in coronary sinus blood collected after periods of ischemia. Inosine was found in small amounts in only 2 of the 10 coronary venous control samples (dogs 9 and II, Table  I ), and in none of the arterial blood samples. However, inosinc was generally present in higher concentrations than hypoxanthine in coronary sinus blood collected during periods of reactive hyperemia.
A distinct adcnosine spot could not be detected in the first chromatogram because of the small amount present and because adenosine migrates in this system at about the same rate as other ultraviolet-absorbing compounds. Therefore, the cellulose between arrows 1 and 2 of the chromatogram (C-I, Fig. 3 ) was extracted and rechromatographed in a different system (C-II, Fig. 3 ). After development of the second chromatogram, only the postischemic coronary venous samples showed a spot in the position of adenosine (Fig. 3, C-II, band 3) . The region between the two arrows (Fig. 3 , C-II) was extracted and the products quantitated whether or not there was a visible adenosine spot present. In the enzymatic quantitation, (Fig. 2, step 10 ) adenosine was not found in any of the arterial or coronary venous control samples, but was present in all coronary venous blood samples collected during the periods of reactive hyperemia ( Table 2) . As a further check on the quantitation of adenosine by enzymatic assay, changes in absorbance were recorded at 240 rnp. If the ratio of the magnitude of the decrement in absorbance at 265 rnh to the increment at 240 rnp remains constant, then the amounts of adenosine calculated from absorbance changes at the two wavelengths will be equal. This proved to be the case (Table 2) .
To obtain further assurance that the compound was indeed adenosine, the products of the adenosine enzymatic assay were extracted and purified according to steps 5-8 of the flow diagram (Fig. 2) . The chromatograms revealed a spot in the inosine position for only those blood samples collected from the coronary sinus during the period of reactive hyperemia (Fig. 3 , C-III, band 3). The optical absorption spectrum of these spots corresponded closely to that of an inosine standard (Fig.  4) . The eluates of the inosine spots were quantitated (Table 2) . Control samples did not reveal the presence of inosine, an expected observation since adenosine was not present in the C-II chromatogram (Fig. 3) .
The amounts of adenosine recovered following the addition of 20, 40, 80, 160, and 400 mpmoles to 100 ml of shed blood are illustrated in coronary sinus blood following infusion of the nucleoside into the coronary sinus cannula, The changes in the circumflex coronary blood flow induced by continuous intracoronary infusion of adenosine at different rates are illustrated in Table 3 . Columns 4 and 5 show the percent increases in coronary blood flow and the concentrations of adenosine in coronary arterial blood, respectively, Infusions of adenosine at the rate of 100 mpmoles/min produced coronary arterial concentrations between 38 and 82 mpmoles/lOO ml (mean value of 56) and increased coronary blood flow to 158-22 1 percent of control. These adenosine-induced increases in coronary blood flow are maximal and equal to the peak flows obtained during the periods of reactive hyperemia following 30-to 60-set coronary occlusions. Peak flows during reactive hyperemia were not increased by coronary occlusions lasting longer than 40 set and increases in the rate of adenosine infusion above 100 mpmoles/min did not elicit a further increase in coronary blood Aow. With infusions of adenosine into the left circumflex coronary artery at rates of 100-200 mpmoles/ min, only 4.6 =t 0.7 (SD) % of the infused adenosine could be recovered in the coronary sinus blood. (4) 40 (4) 100 (4) 4-o (1) 60 (4) 75 (4) 100 (2) 100 (1) 100 (4) 100 (2) 100 ( 82+1  62+1  71&l  60&l  68~t5  394x2  44*3  63+12  84&5  78+0  107&Z  60&l  77&Z  73&l  115+3  102+3  263&Z  40  100  71+1  130+1  65+3  159+2  70+2  180&Z  56  158  50+4  148+5  46+7  145%6  55  122  68&Z  165&12  28+1  71&l 
DISCUSSION
The results indicate that adenosine is released from the myocardium following brief interruption of the coronary circulation, a procedure that has no lasting deleterious effect on the heart as judged from the maintenance of arterial pressure and the reproducibility of the reactive hyperemic responses to repeated arterial occlusions (6) over a period of 2-4 hr.
A precise estimate of the amount of adenosine released during each period of myocardial ischemia cannot be made. However, a rough approximation can bc derived from the amount found in the coronary sinus blood (an amount which increases coronary blood flow about 20 %) and the loss incurred by ad .enosine u elements of the blood. A mean of P take bv the 3 mpmoles cellular adenosine/ 100 ml blood was found in the coronary venous blood collected during the reactive hyperemic period (Table  2) . (Longer p eriods of coronary occlusion (4-7 min) produced concentrations of 50 =I= 8 mpmoles adenosine/W ml coronary sinus blood.) To recover as much as 13 mpmoles from shed blood following a IO-see incubation period at 37 C, it was necessary to add 24 mt,Lmoles of adenosine to 100 ml of blood at time zero (Fig. 5 ). An incubation period of 10 set for th in vitro recovery studies was chosen because it is al proximately the time of contact between the adenosine released bv the heart and the blood in the in vivo experiments.
Thus, it can be inferred that the myocardium added 12 mf,cmoles of adenosinc to each 50 ml of perfusing blood (50 ml was the volume of each individual blood sample collected). Because of the high adenosine deaminase activity within myocardial cells (2, 5) it can be assumed that the adenosine was all within the extracellular space (interstitial plus intravascular) just prior to release of the occluded coronary artery and that it was rapidly washed out of the heart by the blood when the circulation was reestablished.
If the extracellular space is assumed to be 20 % of the wet weight of the heart ( 1, 15, 18), then 80 g (average wet weight in these experiments) of left ventricle would have an extracellular volume of 16 ml with a concentration of adenosine of 75 mpmoles/ 100 ml (( 12/ 16) X 100) of extracellular fluid. This is the estimated minimum concentrati on of the vascular smooth muscle of the aclenosine arterioles to which would bc exposed.
Intracoronary administration of adenosine at concentrations of 56 m~moles/lOO ml of blood products maximal dilation of the coronary resistance vessels. Thus, it is apparent that with 40 set of myocardial ischemia, the concentration of adenosine in contact with the arterioles is greater than that required to elicit maximal coronary dilation. In all likelihood, maximal coronary dilation is probably achieved with concentrations of adenosine less than 56 m~moles/l00 ml of arterial blood since some adenosine undoubtedly enters the red cells in the time required for the blood to pass from the site of adenosine infusion to the site of its action on the coronary resistance vessels.
Other undetermined factors which bear on the accuracy of the estimate of th .e concentration of ad enosine calcula ted to exist at the arteriolar vascular smooth muscle are the rate and duration of rcleasc of adenosine from the myocardial cells, the rate of reentry of adenosine into the myocardial cells from the extracellular cornpartmerit ( lo), the amount of blood collected during the period of reactive hyperemia, and the percent of left ventricular coronary blood flow that enters the coronary sinus. If a significant fraction of the adenosine recovered from the 50 ml of coronary sinus blood collected during each period of reactive hyperemia leaves the myocardial cells during this period and is not already present in the extracellular compartment at the time of release of the occluded coronary artery, the concentration calculated to be in contact with the arterioles will be too high. However, it is not likely that a large pool of adenosine builds up within the rnyocardial cells due to the high adcnosine deaminase activity and it is also unlikely that net adenosine production occurs long after reestablishment of the coronary circulation. by ATP-activated adenylic acid deaminase (5). Furthermore, the low 5'-nucleotidase concentration in the interior of the myocardial cell and its inhibition by ATP (2, 5) make AMP hydrolysis to adenosine less likely than its deamination to IMP. Therefore, it appears rcasonablc to suggest that the adenosine released in the present studies is formed at the myocardial cell membranes. Once the adenosine has entered the interstitial fluid, it should reach equilibriurn with the small amount of blood trapped in the exchange vcsscls of the heart and some should be lost into the cellular elements of the blood. In addition, some adenosine probably reenters the myocardial cells because a) the intramyocardial concentration is presumably low due to the activity of the adcnosine deaminase, 6) only 5 % of the adenosine infused into the left circumflex coronary artery can be recovered from the coronary sinus blood, and c) even the hypoxic heart avidly takes up adenosine and incorporates it into adenine nucleotides ( 1 I). Hence, the effective extracellular concentration of adenosine during the period of ischemia is determined by the balance between release and uptake of the nucleoside by the cells. If the amount of blood collected (50 ml) during the period of reactive hyperemia is insufficient to wash out all the adenosine that accumulated during the period of ischc that mia, calcr then a higher CO11 xl ated would be tion of adcn osi nc than t in the ex trace llular space, Finally, the estimate of adenosine in the extracellular space is also low because only about three-fourths of left coronary inflow reaches the coronary sinus. Consequently, one-fourth of the adenosine present in the extracellular space at the end of the ischemic period would not be measured.
To date, adenosine has not been found in normal, adequately oxygenated cardiac tissue. However, with prolonged ischemia, it reaches levels of 10P7 moles/g ( 7-9, 16), a concentration far in excess of that required to elicit maximal coronary dilation, If adenosine plays a role in the normal modulation of coronary vascular resistance, and if it is assumed that the adenosine in the myocardium is extracellular, then the amounts present in the well-oxygenated heart arc below levels detectable by
